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INTRODUCTION
The Idaho National Laboratory (INL), the 
University of Washington (UW) Neutron 
Therapy Center, the University of Essen 
(Germany) Neutron Therapy Clinic, and the 
Northern Illinois University(NIU) Institute for 
Neutron Therapy at Fermilab have been 
collaborating in the development of fast-neutron 
therapy (FNT) with concurrent neutron capture 
(NCT) augmentation [1,2].   As part of this 
effort, we have conducted measurements to 
produce suitable benchmark data as an aid in 
validation of advanced three-dimensional 
treatment planning methodologies required for 
successful administration of FNT/NCT.    
Free-beam spectral measurements as well as 
phantom measurements with LuciteTM cylinders 
using thermal, resonance, and threshold 
activation foil techniques have now been 
completed at all three clinical accelerator 
facilities.  The same protocol was used for all 
measurements to facilitate intercomparison of 
data.    The results will be useful for further 
detailed characterization of the neutron beams of 
interest as well as for validation of various 
charged particle and  neutron transport codes and 
methodologies for FNT/NCT computational 
dosimetry, such as MCNP [3],  LAHET [4], and 
MINERVA [5].  
METHODS AND MATERIALS
Figure 1 shows the three treatment facilities, 
each with the same Lucite phantom in position 
for irradiation, with the isocenter of the beam 
located at the center of the top phantom surface 
in each case. The phantom has a diameter of 15.2 
cm and a height of 21.6 cm. The field size at the 
isocenter was set as closely as possible to 8.0 cm 
x 8.0 cm for all irradiations.  The UW treatment 
        
Figure 1.  Neutron therapy treatment facilites -  
UW (Top), Essen (Center), and Fermilab 
(Bottom). 
facility has a 10.5 mm thick beryllium neutron 
production target mounted in the gantry – this is 
the standard target used for therapy at UW.   A 
proton beam is incident on the target at a current 
of approximately 67 microamperes effective DC, 
with a nominal proton energy of 50.5 MeV.  The 
Essen neutron source [6], also gantry mounted, is 
produced by a 14 MeV, 75 mA deuteron beam 
incident on a 5 mm thick beryllium target.  The 
Fermilab facility features a fixed (non-gantry) 
beam, with a somewhat harder neutron energy 
spectrum produced by 66 MeV protons 
impinging at a current of approximately 25 
microamperes on a 22.1 mm thick beryllium 
target in these experiments.  Patient positioning 
at Fermilab is accomplished by a chair that has 
the capability of precise rotation and translation 
to produce essentially any beam-patient 
orientation desired.  The target-to-isocenter 
distances are 1.5 m, 1.9 m and 1.25 m for the 
UW, Fermilab and Essen facilities, respectively.   
Several different types of foil packages 
containing gold, manganese, aluminum, copper, 
and indium foils of various thicknesses, with and 
without cadmium covers, were placed at various 
depths along the central axis of the phantom.  
After the completion of each irradiation,  the 
induced activities produced by the various 
interactions of interest in the foils were measured 
by gamma-ray spectrometry, and the results were 
converted to saturation activities. 
RESULTS AND DISCUSSION 
Figure 2 shows some typical results for the 
activation of bare and cadmium-covered 0.0254 
mm (1 mil) thick gold foils via the interaction 
197Au(n,Ȗ)198Au as a function of depth along the 
phantom centerline for the three beams, 
normalized to the charged particle current 
incident on target in each case. Uncertainties are 
comparable to the size of the data points shown. 
With cadmium covers on the foil packages, the 
activation of gold by neutron capture is largely 
due to resonance neutron absorption at the 
primary resonance energy (5 eV) and above.  
Measurements using uncovered foils also include 
activation by thermal neutrons, of particular 
interest for NCT applications.  The relative 
magnitudes of the activation rates produced by 
the three beams are consistent with the different 
target-isocenter distances and the incident 
charged particle beam energies for each case.  
Measurements were also made with heavier 
0.254 mm (10 mil) foils in order to obtain useful 
data for several 197Au (n,xn) threshold reactions 
in gold as well, where x is as high as 6.  These 
interactions are sensitive to neutrons of higher 
and higher energies as x increases, providing 
additional spectral information as a function of 
depth in each case.   
      
This information, along with information [7] 
from the numerous other thermal, resonance, and 
threshold interactions in the other foils in the 
phantom described here, as well as in a smaller 
phantom that has a different spectral sensitivity, 
allows the development of a self-consistent 
picture of the space and energy dependent 
behavior of the neutron flux in a representative 
application.  Free-beam spectral measurements 
have also been completed using various foil 
packages placed at the beam isocenter.   Taken 
as a whole, this will provide benchmark data for 
validation of computations required for beam 
characterization and treatment planning.  
Intercomparison of the performance of the 
neutron beams at the three facilities on a 
common basis will also be facilitated.   
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Figure 2.  Saturation activity of 198Au in  0.0254 
mm thick gold foils as a function of depth along 
the phantom centerline for the three beams. Units 
are activations per second per atom per 
microampere of incident charged particle current 
on target.   
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